Cholesterol-lowering drugs for primary prevention? The WOSCOP Study

Pharmacol Res. 1997 Mar;35(3):169-70. doi: 10.1006/phrs.1996.0136.

Author

S Muntoni¹

Affiliation

¹ Centre for Metabolic Diseases and Atherosclerosis, The ME.DI.CO. Association, Cagliari, Italy.

PMID: 9229402
DOI: 10.1006/phrs.1996.0136

No abstract available

MeSH terms

Anticholesteremic Agents / pharmacology*
Anticholesteremic Agents / therapeutic use
Cholesterol / blood
Coronary Disease / mortality
Coronary Disease / prevention & control*
Humans
Hypercholesterolemia / blood
Hypercholesterolemia / drug therapy
Male
Middle Aged
Pravastatin / pharmacology*
Pravastatin / therapeutic use
Randomized Controlled Trials as Topic
Risk Factors
Scotland / epidemiology

Substances

Anticholesteremic Agents
Cholesterol
Pravastatin